Generate Biomedicines Inc. (GENB) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Generate Biomedicines Inc., updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$15.38
+16.43% today
Market cap
$1.7B
Overall quality
42/100
Kronos AI 30-day
+9.5%
7 of 8 simulated paths end higher
Generate Biomedicines Inc. (GENB) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $1.7B. It trades at $15.38, up 16.43% today. Its overall quality score is 42 out of 100, ranked against the whole US market. 3 analysts' average target of $26.00 implies +69.1% from today's price. Kronos AI's 30-day forecast is +9.5% (7 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $26.00 |
| Low – high | $22.00 – $30.00 |
| Analysts | 3 |
| Upside to average | +69.1% |
Kronos AI 30-day forecast
| Expected close | $14.46 (+9.5%) |
| Likely range | +1.8% … +15.6% |
| As of | 2026-10-27 |
7 of 8 simulated paths end higher.
Quality scores
| Profitability | 30 |
| Solvency | 60 |
| Growth | 35 |
| Overall | 42 |
| P/E | — |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Halal Health Care stocks · Zakat calculator · Purification calculator
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.